Blaslov, K., Zibar, K., Bulum, T. & Duvnjak, L. (2014). Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients. Clinics and Research in Hepatology and Gastroenterology, 38. (3), e61-e63. doi: 10.1016/j.clinre.2013.10.013
Blaslov, Kristina, et al. "Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients." Clinics and Research in Hepatology and Gastroenterology, vol. 38, no. 3, 2014, pp. e61-e63. https://doi.org/10.1016/j.clinre.2013.10.013
Blaslov, Kristina, Karin Zibar, Tomislav Bulum and Lea Duvnjak. "Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients." Clinics and Research in Hepatology and Gastroenterology 38, no. 3 (2014): e61-e63. https://doi.org/10.1016/j.clinre.2013.10.013
Blaslov, K., et al. (2014) 'Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients', Clinics and Research in Hepatology and Gastroenterology, 38(3), pp. e61-e63. doi: 10.1016/j.clinre.2013.10.013
Blaslov K, Zibar K, Bulum T, Duvnjak L. Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients. Clinics and Research in Hepatology and Gastroenterology [Internet]. 2014 June [cited 2024 October 28];38(3):e61-e63. doi: 10.1016/j.clinre.2013.10.013
K. Blaslov, K. Zibar, T. Bulum and L. Duvnjak, "Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients", Clinics and Research in Hepatology and Gastroenterology, vol. 38, no. 3, pp. e61-e63, June 2014. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:523982. [Accessed: 28 October 2024]
